Similarly, for 90% of the patients from the ID-MUT study, the EGFR genotyping result was determined to be 15–16 cd (10–11 wd) after tumor sampling with the IdyllaTM method, against 23–24 cd (19–20 wd) for the NGS method. Here, EGFR is linked to neoplasm.